Azathioprine treatment in active chronic hepatitis. Evaluation of dose levels.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D005260:Female; D006505:Hepatitis / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D008099:Liver / Q000378:metabolism; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012709:Serum Albumin / Q000032:analysis; D012712:Serum Globulins / Q000032:analysis
D012709:Serum Albumin; D012712:Serum Globulins; D000410:Alanine Transaminase; D001379:Azathioprine